Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
AmgenAMGN |
77 1.3% |
 |
Gilead SciencesGILD |
57 0% |
 |
Catalyst PharmaceuticalsCPRX |
100 0% |
 |
Inovio PharmaceuticalsINO |
23 0% |
 |
Anavex Life SciencesAVXL |
0 0% |
Month over Month
Employee view on business outlook (0 - 100)
| Oct 2024 | 85 | |
| Sep 2024 | 86 | |
| Aug 2024 | 97 | |
| Jul 2024 | 97 |
How do employees feel about the future at Sarepta Therapeutics?
The Business Outlook at Sarepta Therapeutics is positive according to its employees. The average outlook rating 85 (out of 100) is high.
Analyzing Business Outlook, how is Sarepta Therapeutics performing compared to its industry peers?
Sarepta Therapeutics overperforms a majority of its industry peers when it comes to Business Outlook, ranking in the 85th percentile.
How has the business outlook at Sarepta Therapeutics changed over the last couple of months
In recent months, Sarepta Therapeutics' employees have reported a shift towards a more negative business outlook, suggesting declining company morale and potentially leading to decreased market competitiveness and diminished company performance.
Why is it important to track the business outlook at Sarepta Therapeutics?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at Sarepta Therapeutics.
